Convalescence, Ischemic Stroke
Conditions
Keywords
Ischemic Stroke, Convalescence, Randomized Controlled Trial, Pilot Study, Traditional Chinese Medicine
Brief summary
To evaluate the effect of the dynamic combination therapy on Chinese herbal granule formula (Fangji) based on differentiation of syndromes (Zhenghou) according to the theory of traditional Chinese medicine for improving the symptoms in the convalescent phase of ischemic stroke, and to establish the pharmacodynamic model of Zhenghou according to the results of this trial.
Interventions
DRUGDynamic Chinese herbal granule formula
After evaluated the style of the syndrome (Zhenghou) by an experienced integrative medicine doctor, the patients should be given a Chinese herbal granule formula twice a day for 4 weeks, which should be selected from 10 kinds of Chinese herbal granules and weekly changed according to differentiation of syndromes (Zhenghou) of patients.
DRUGPlacebo
The 10 kinds of matched placebo granules were of the similar appearance, taste, smell with the corresponding Chinese herbal granules respectively. The interventional process of the placebo group is similar as the Chinese herbal granule formula group
PROCEDUREStandard medical care
Standard medical care is the basic treatment for all enrolled patients, including aspirin 75-100mg per day, standard rehabilitation training, treatment for their primary diseases, etc.
Sponsors
National Natural Science Foundation of China
China Academy of Chinese Medical Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Age: 18 - 75 years. * Clinical diagnosis of ischemic stroke causing a measurable neurological deficit defined as impairment of language, motor function, cognition and/or gaze, vision or neglect, confirmed by CT or MRI scan. * Clinical diagnosis of Qixu-Xueyu Zheng (Qi deficiency and Blood Stasis Syndrome) as the scores of Chinese medicine symptoms scales in ischemic stroke on both Qixue and Xueyu ≥ 7. * 15 days to 60 days after onset of symptoms. * Clinical diagnosis of cerebral anterior circulation obstruction. * 4≤NIHSS\<20. * Patient is willing to participate voluntarily and to sign a written patient informed consent.
Exclusion criteria
* Transient ischemic attack * Evidence of intracranial hemorrhage (ICH) in 6 months * Evidence of other cerebral diseases (eg.vascular malformation, tumor, abscess or multiple sclerosis etc.)on the CT or MRI scan. * Woman with pregnancy, lactation or positive result of pregnancy test, or women who want to be pregnant in recent 6 months. * Woman who is under menstrual period. * Known history of allergy or suspected allergic to these chinese herbs. * Complicated with atrial fibrillation. * Fasting blood glucose ≥8 mmol / l under the treatment of diabetes or complicated with severe cardio-cerebrovascular diseases (eg. hyperlipemia, coronary heart disease with angina attack ≥ 4 times a day). * Liver function impairment with the value of ALT or AST over 1.5-fold of normal value. * Renal dysfunction with the value of serum creatinine over normal value. * Prior disable patients or complicated with osteoarthropathy that influence the motor function of the limbs. * With mental disorder that can not cooperate with doctor * Suspected addicted into alcohol or drug abuse. * With severe complications that would make the condition more complicated assessed by the investigator. * Patient who is participating in other trials or has been participated in other trials in recent 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom Scale of the Qixu-Xueyu Zheng(Qi Deficiency and Blood Stasis Syndrome) according to the theory of Traditional Chinese Medicine at Day 28 | Day 28 |
Secondary
| Measure | Time frame |
|---|---|
| modified Rankin Scale | Day0; Day 7; Day 14; Day 21; Day 28; Day 90 after Onset |
| NIH stroke scale(NIHSS) | Day 0; Day7; Day 14; Day 21; Day 28; Day 90 after onset |
| EQ-5D scale | Day0; Day 7; Day 14; Day 21; Day 28; Day 90 after Onset |
| Bathel Index | Day0; Day 7; Day 14; Day 21; Day 28; Day 90 after Onset |
| Incidence of Recurrent Stroke | Day 90 after onset this time |
| Incidence of new-onset vascular events | Day 90 after onset this time |
| Incidence of adverse events (AEs) and serious AEs | From Day 0 to Day 90 after onset |
| Overall mortality at day 90 | Day 90 after onset |
Countries
China
Outcome results
None listed